Remove 2024 Remove Blood Clot Remove Pulmonary
article thumbnail

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

DAIC

They looked at anonymous results for 57,531 adult patients who underwent pulmonary resection—removal of all or part of a lung—between January 2009 and June 2021. Of these patients, 758 developed blood clots that moved to the lungs after surgery. In this contemporary analysis of the GTSD, the research team identified a 2.5%

Cancer 116
article thumbnail

Avicenna.AI Secures FDA Clearance for Two Healthcare AI Solutions

DAIC

milla1cf Tue, 03/26/2024 - 11:12 March 26, 2024 — Medical imaging AI company Avicenna.AI announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products. CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI

Embolism 105
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health. Edwards EVOQUE Tricuspid Valve Replacement System (Approved: 02/01/2024) This system provides a novel approach to tricuspid valve replacement, potentially benefiting patients with tricuspid regurgitation without open-heart surgery.

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Image courtesy: Getty Images christine.book Wed, 07/24/2024 - 09:00 July 24, 2024 — Volta Medical , a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, has announced a Joint Development Agreement with GE HealthCare. "As

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024. The company now anticipates U.S. Caution: Investigational Device.

article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

Among those ages 65 and older, nearly 50% who underwent limb amputation died within one year after surgery, according to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. Approximately 10 million to 12 million adults ages 40 and older in the U.S. have PAD, which increases the risk of amputation, heart attack, stroke and death.

article thumbnail

Women and Black Patients Less Likely to Receive Catheter-based Treatment for Pulmonary Embolism According to REAL-PE Analysis Presented at SCAI 2024

DAIC

Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Its SCAI Scientific Sessions 2024 were held May 2-4 in Long Beach, CA.

Embolism 122